Association of Kidney Function with Changes in the Endothelial Surface Layer

被引:109
作者
Dane, Martijn J. C. [1 ,2 ]
Khairoun, Meriem [1 ]
Lee, Dae Hyun [1 ]
van den Berg, Bernard M. [1 ]
Eskens, Bart J. M. [2 ]
Boels, Margien G. S. [1 ]
van Teeffelen, Jurgen W. G. E. [2 ]
Rops, Angelique L. W. M. M. [3 ]
van der Vlag, Johan [3 ]
van Zonneveld, Anton Jan [1 ]
Reinders, Marlies E. J. [1 ]
Vink, Hans [2 ]
Rabelink, Ton J. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Nephrol, Einthoven Lab Vasc Med, NL-2333 ZA Leiden, Netherlands
[2] Maastricht Univ, Dept Physiol, Med Ctr, Maastricht, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 04期
关键词
CHRONIC-RENAL-FAILURE; CARDIOVASCULAR-DISEASE; IN-VIVO; GLYCOCALYX DIMENSIONS; DIABETES-MELLITUS; TNF-ALPHA; DYSFUNCTION; CELLS; ISCHEMIA; DAMAGE;
D O I
10.2215/CJN.08160813
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectivesESRD is accompanied by endothelial dysfunction. Because the endothelial glycocalyx (endothelial surface layer) governs interactions between flowing blood and the vessel wall, perturbation could influence disease progression. This study used a novel noninvasive sidestream-darkfield imaging method, which measures the accessibility of red blood cells to the endothelial surface layer in the microcirculation (perfused boundary region), to investigate whether renal function is associated with endothelial surface layer dimensions.Design, setting, participants, & measurementsPerfused boundary region was measured in control participants (n=10), patients with ESRD (n=23), participants with normal kidney function after successful living donor kidney transplantation (n=12), and patients who developed interstitial fibrosis/tubular atrophy after kidney transplantation (n=10). In addition, the endothelial activation marker angiopoietin-2 and shed endothelial surface layer components syndecan-1 and soluble thrombomodulin were measured using ELISA.ResultsCompared with healthy controls (1.820.16 mu m), ESRD patients had a larger perfused boundary region (+0.23; 95% confidence interval, 0.46 to <0.01; P<0.05), which signifies loss of endothelial surface layer dimensions. This large perfused boundary region was accompanied by higher circulating levels of syndecan-1 (+57.71; 95% confidence interval, 17.38 to 98.04; P<0.01) and soluble thrombomodulin (+12.88; 95% confidence interval, 0.29 to 25.46; P<0.001). After successful transplantation, the perfused boundary region was indistinguishable from healthy controls (without elevated levels of soluble thrombomodulin or syndecan-1). In contrast, however, patients who developed interstitial fibrosis and tubular atrophy showed a large perfused boundary region (+0.36; 95% confidence interval, 0.09 to 0.63; P<0.01) and higher levels of endothelial activation markers. In addition, a significant correlation between perfused boundary region, angiopoietin-2, and eGFR was observed (perfused boundary region versus GFR: Spearman's =0.31; P<0.05; perfused boundary region versus angiopoietin-2: Spearman's =-0.33; P<0.05).ConclusionReduced renal function is strongly associated with low endothelial surface layer dimensions. After successful kidney transplantation, the endothelial surface layer is indistinguishable from control.
引用
收藏
页码:698 / 704
页数:7
相关论文
共 40 条
  • [1] Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: Possible application as a marker for vascular endothelial injury
    Aso, Y
    Inukai, T
    Takemura, Y
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (03): : 362 - 365
  • [2] Bartlett AH, 2007, MOL CELLS, V24, P153
  • [3] Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential
    Becker, Bernhard F.
    Chappell, Daniel
    Bruegger, Dirk
    Annecke, Thorsten
    Jacob, Matthias
    [J]. CARDIOVASCULAR RESEARCH, 2010, 87 (02) : 300 - 310
  • [4] Boehme MWJ, 1996, IMMUNOLOGY, V87, P134
  • [5] The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome
    Boels, Margien G. S.
    Lee, Dae Hyun
    van den Berg, Bernard M.
    Dane, Martijn J. C.
    van der Vlag, Johan
    Rabelink, Ton J.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (06) : 503 - 509
  • [6] Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
    Broekhuizen, L. N.
    Lemkes, B. A.
    Mooij, H. L.
    Meuwese, M. C.
    Verberne, H.
    Holleman, F.
    Schlingemann, R. O.
    Nieuwdorp, M.
    Stroes, E. S. G.
    Vink, H.
    [J]. DIABETOLOGIA, 2010, 53 (12) : 2646 - 2655
  • [7] Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease
    Broekhuizen, Lysette N.
    Mooij, Hans L.
    Kastelein, John J. P.
    Stroes, Erik S. G.
    Vink, Hans
    Nieuwdorp, Max
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (01) : 57 - 62
  • [8] The Glycocalyx of the Human Umbilical Vein Endothelial Cell An Impressive Structure Ex Vivo but Not in Culture
    Chappell, Daniel
    Jacob, Matthias
    Paul, Oliver
    Rehm, Markus
    Welsch, Ulrich
    Stoeckelhuber, Mechthild
    Conzen, Peter
    Becker, Bernhard F.
    [J]. CIRCULATION RESEARCH, 2009, 104 (11) : 1313 - 1317
  • [9] Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface
    Constantinescu, AA
    Vink, H
    Spaan, JAE
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) : 1541 - 1547
  • [10] Glomerular Endothelial Surface Layer Acts as a Barrier against Albumin Filtration
    Dane, Martijn J. C.
    van den Berg, Bernard M.
    Avramut, M. Cristina
    Faas, Frank G. A.
    van der Vlag, Johan
    Rops, Angelique L. W. M. M.
    Ravelli, Raimond B. G.
    Koster, Bram J.
    van Zonneveld, Anton Jan
    Vink, Hans
    Rabelink, Ton J.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (05) : 1532 - 1540